Brazil Says "No" To Covaxin, Bharat Biotech Explains

According to reports, a Brazilian government gazette had said that Covaxin had been rejected "considering the non-compliance with the requirements of Good Manufacturing Practices for Medicines''.

Brazil's health regulator has denied permission to import Covaxin,  the Covid vaccine produced by indigenous firm Bharat Biotech. Twenty million doses of the vaccine has been ordered by Brazil, the nation hit worst by Covid after the United States. According to reports, a Brazilian government gazette had said that Covaxin had been rejected "considering the non-compliance with the requirements of Good Manufacturing Practices for Medicines''. In its response, Bharat Biotech has told NDTV: ''The requirements pointed out during inspection will be fulfilled, the timelines for fulfilment is under discussion with the Brazil NRA and will be resolved soon.'' Covaxin, produced by Bharat Biotech in collaboration with the Indian Council for Medical Research, was approved for emergency use by the national drug regulator in January. The vaccine was expected to be used only in the "clinical trial mode".